// App-Quantinova.ai

e12078 : Germline mutation in the KLRC2 gene to inform intrinsic resistance and inferior responses to trastuzumab in breast cancer.

Researchers

Presenter

  • Fengrui Xu

Principal Investigators

  • Li Bian

  • Yujuan Zhou

  • Ge Du

  • Jianbin Li

  • Tao Wang

  • Shaohua Zhang

  • Santai Song

  • Zefei Jiang

Medical Centers

  • The Hospital Affiliated to Military Medical Science, Beijing, China

  • Chinese Human Genome Research Center, Beijing, China

  • Department of Breast Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China

  • Department of Breast Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved